16.4 per 1,000 person-years
Chat is your fastest path to a real person
Only a small number of research studies have looked into Semaglutide anxiety symptoms
Quick Answer: Headache is a recognised side effect of GLP-1 receptor agonists, classified as common (1 in 10 to 1 in 100 people) for diabetes formulations and very common (more than 1 in 10) for weight-management doses
JAMA Network Open, 7 (9), e2433326
Theres probably 50 years of research, and theyve been available for 20 years longer than most people realize, says Rekha Kumar, MD, an endocrinologist and obesity medicine expert at Weill Cornell Medical College and NewYork-Presbyterian Hospital in New York City